Global Autoimmune Disease Testing Market Size study & Forecast, by Product Type (Instruments, Reagents & Consumables), by Disease Type (Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE), Scleroderma, Vasculitis, Inflammatory Bowel Disease (IBD), Others), by Test Type (Antinuclear Autoantibody (ANA), Rheumatoid Factor (RF), C-Reactive Protein (CRP), Anti-Thyroglobulin Antibody (ATA), Others), by End-User (Hospital & Clinics, Diagnostic Centers, Others), and Regional Analysis 2023-2030
Global Autoimmune Disease Testing Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over during the forecast period 2023-2030. Autoimmune disease testing encompasses a variety of diagnostic procedures aimed at identifying and evaluating autoimmune conditions, where the body's immune system mistakenly attacks its own tissues. These tests include blood tests to measure specific antibodies and proteins indicative of autoimmune activity, autoantibody tests to detect antibodies targeting the body's tissues, imaging tests to visualize affected organs, and sometimes biopsies for tissue examination. Prompt and accurate autoimmune disease testing is crucial for early diagnosis, monitoring disease progression, and guiding appropriate treatment strategies. Early detection enables timely intervention to manage symptoms and prevent complications, leading to improved patient outcomes and quality of life. Basic tests including antinuclear autoantibody, rheumatoid Rheumatoid factor Factor (RF), and others so on are frequently required for the diagnosis of autoimmune illnesses. These tests assist manage and diagnose autoimmune disease patients, offer a prognosis, or reveal the extent of organ involvement or damage. The growing awareness regarding autoimmune diseases, rising automation in a laboratory, and the introduction of novel products for autoimmune disease diagnostics are the key factors that are stipulating the market demand during the estimated years of 2023-2030.
In addition, the rising prevalence of autoimmune diseases is acting as a major driving factor for market growth across the globe . For instance, according to According to an NCBI article from September 2022, the incidence of rheumatoid arthritis was reported at 24 cases per 100,000 people in Northern Europe and 36 cases per 100,000 people in Northern America. Likewise, another NCBI article published in 2021 indicated a global increase in osteoarthritis prevalence, ranging from 8.5% to 9.3% in 2021.the NCBI article published in September 2022, the incidence of rheumatoid arthritis in Northern Europe and Northern America was 24 and 36 cases per 100,000 people, respectively. Similarly, another NCBI article published in 2021 mentioned that globally, osteoarthritis prevalence increased by 8.5%-9.3% in 2021. Thus, the increasing prevalence of autoimmune diseases these aforementioned factors are likely to augment the market growth at a substantial rate. Further, the rising adoption of biosensors for autoimmune disease testing, as well as growing expenditure on R&D activities are leveraging various opportunities over the forecasting forecast years. However, the lack of penetration of these products in developing regions and lack of awareness of these diseases amongst the general population stifles market growth throughout the forecast period of 2022-2030.
The key regions considered for the Global Autoimmune Disease Testing Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the growing focus on R&D for the development of new testing options and the presence of leading market players. Moreover, strategic initiatives in this region have propelled it to a leading market position. For example, in January 2020, Progentec Diagnostics, Inc. secured USD 5 million in funds. The company intends to utilize this investment to create an extensive solution for effectively managing lupus patients through highly sensitive and specific continuous remote digital monitoring. Furthermore, the growing emphasis on research and development to introduce novel testing options is expected to bolster regional market growth in the forecast period. Whereas, the Asia Pacific is expected to grow with the highest CAGR during over the forecast period, owing to factors such as the rising prevalence of target diseases, as well as the increasing geriatric population in the regional market.
Major market players included in this report are:
F. Hoffmann-La Roche Ltd
Siemens Healthcare GmbH
Thermo Fisher Scientific Inc.
Quest Diagnostics Incorporated
Abbott
Werfen
Trinity Biotech PLC
Bio-Rad Laboratories, Inc.
ORGENTEC Diagnostika GmbH
Cambridge Life Sciences Limited
Recent Developments in the Market:
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product Type:
Instruments
Reagents & Consumables
By Disease Type:
Rheumatoid Arthritis (RA)
Systemic Lupus Erythematosus (SLE)
Scleroderma
Vasculitis
Inflammatory Bowel Disease (IBD)
Others
By Test Type:
Antinuclear Autoantibody (ANA)
Rheumatoid Factor (RF)
C-Reactive Protein (CRP)
Anti-Thyroglobulin Antibody (ATA)
Others
By End-User:
Hospital & Clinics
Diagnostic Centers
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
In addition, the rising prevalence of autoimmune diseases is acting as a major driving factor for market growth across the globe . For instance, according to According to an NCBI article from September 2022, the incidence of rheumatoid arthritis was reported at 24 cases per 100,000 people in Northern Europe and 36 cases per 100,000 people in Northern America. Likewise, another NCBI article published in 2021 indicated a global increase in osteoarthritis prevalence, ranging from 8.5% to 9.3% in 2021.the NCBI article published in September 2022, the incidence of rheumatoid arthritis in Northern Europe and Northern America was 24 and 36 cases per 100,000 people, respectively. Similarly, another NCBI article published in 2021 mentioned that globally, osteoarthritis prevalence increased by 8.5%-9.3% in 2021. Thus, the increasing prevalence of autoimmune diseases these aforementioned factors are likely to augment the market growth at a substantial rate. Further, the rising adoption of biosensors for autoimmune disease testing, as well as growing expenditure on R&D activities are leveraging various opportunities over the forecasting forecast years. However, the lack of penetration of these products in developing regions and lack of awareness of these diseases amongst the general population stifles market growth throughout the forecast period of 2022-2030.
The key regions considered for the Global Autoimmune Disease Testing Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the growing focus on R&D for the development of new testing options and the presence of leading market players. Moreover, strategic initiatives in this region have propelled it to a leading market position. For example, in January 2020, Progentec Diagnostics, Inc. secured USD 5 million in funds. The company intends to utilize this investment to create an extensive solution for effectively managing lupus patients through highly sensitive and specific continuous remote digital monitoring. Furthermore, the growing emphasis on research and development to introduce novel testing options is expected to bolster regional market growth in the forecast period. Whereas, the Asia Pacific is expected to grow with the highest CAGR during over the forecast period, owing to factors such as the rising prevalence of target diseases, as well as the increasing geriatric population in the regional market.
Major market players included in this report are:
F. Hoffmann-La Roche Ltd
Siemens Healthcare GmbH
Thermo Fisher Scientific Inc.
Quest Diagnostics Incorporated
Abbott
Werfen
Trinity Biotech PLC
Bio-Rad Laboratories, Inc.
ORGENTEC Diagnostika GmbH
Cambridge Life Sciences Limited
Recent Developments in the Market:
- In March 2022, Siemens Healthcare GmbH unveiled that the company received the designation of an innovative device for its ADVIA Centaur serum Neurofilament Light Chain (sNfL) assay, which was advanced with the collaboration with Novartis AG to identify adult patients with multiple sclerosis.
- In May 2022, Thermo Fisher Scientific Inc. announced that its new Phadia 2500+ range of instruments are is available throughout the United States. These devices are used to check people with autoimmune diseases, including autoimmune thyroid illness, autoimmune liver disease, rheumatoid arthritis, and celiac disease.The devices are used to examine patients with autoimmune conditions such celiac disease, rheumatoid arthritis, autoimmune liver disease, and autoimmune thyroid illness.
- Historical Data – 2020 - 2021
- Base Year for Estimation – 2022
- Forecast period - 2023-2030
- Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
- Segments Covered - Product Type, Disease Type, Test Type, End-user, Region
- Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
- Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product Type:
Instruments
Reagents & Consumables
By Disease Type:
Rheumatoid Arthritis (RA)
Systemic Lupus Erythematosus (SLE)
Scleroderma
Vasculitis
Inflammatory Bowel Disease (IBD)
Others
By Test Type:
Antinuclear Autoantibody (ANA)
Rheumatoid Factor (RF)
C-Reactive Protein (CRP)
Anti-Thyroglobulin Antibody (ATA)
Others
By End-User:
Hospital & Clinics
Diagnostic Centers
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Autoimmune Disease Testing Market, by Region, 2020-2030 (USD Billion)
1.2.2. Autoimmune Disease Testing Market, by Product Type, 2020-2030 (USD Billion)
1.2.3. Autoimmune Disease Testing Market, by Disease Type, 2020-2030 (USD Billion)
1.2.4. Autoimmune Disease Testing Market, by Test Type, 2020-2030 (USD Billion)
1.2.5. Autoimmune Disease Testing Market, by End-user, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL AUTOIMMUNE DISEASE TESTING MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL AUTOIMMUNE DISEASE TESTING MARKET DYNAMICS
3.1. Autoimmune Disease Testing Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing automation in a laboratory
3.1.1.2. Rising prevalence of autoimmune diseases
3.1.2. Market Challenges
3.1.2.1. Lack of penetration of these products in developing regions
3.1.2.2. Lack of awareness of these diseases amongst the general population
3.1.3. Market Opportunities
3.1.3.1. Rising adoption of biosensors for autoimmune disease testing
3.1.3.2. Growing expenditure on R&D activities
CHAPTER 4. GLOBAL AUTOIMMUNE DISEASE TESTING MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL AUTOIMMUNE DISEASE TESTING MARKET, BY PRODUCT TYPE
5.1. Market Snapshot
5.2. Global Autoimmune Disease Testing Market by Product Type, Performance - Potential Analysis
5.3. Global Autoimmune Disease Testing Market Estimates & Forecasts by Product Type 2020-2030 (USD Billion)
5.4. Autoimmune Disease Testing Market, Sub Segment Analysis
5.4.1. Instruments
5.4.2. Reagents & Consumables
CHAPTER 6. GLOBAL AUTOIMMUNE DISEASE TESTING MARKET, BY DISEASE TYPE
6.1. Market Snapshot
6.2. Global Autoimmune Disease Testing Market by Disease Type, Performance - Potential Analysis
6.3. Global Autoimmune Disease Testing Market Estimates & Forecasts by Disease Type 2020-2030 (USD Billion)
6.4. Autoimmune Disease Testing Market, Sub Segment Analysis
6.4.1. Rheumatoid Arthritis (RA)
6.4.2. Systemic Lupus Erythematosus (SLE)
6.4.3. Scleroderma
6.4.4. Vasculitis
6.4.5. Inflammatory Bowel Disease (IBD)
6.4.6. Others
CHAPTER 7. GLOBAL AUTOIMMUNE DISEASE TESTING MARKET, BY TEST TYPE
7.1. Market Snapshot
7.2. Global Autoimmune Disease Testing Market by Test Type, Performance - Potential Analysis
7.3. Global Autoimmune Disease Testing Market Estimates & Forecasts by Test Type 2020-2030 (USD Billion)
7.4. Autoimmune Disease Testing Market, Sub Segment Analysis
7.4.1. Antinuclear Autoantibody (ANA)
7.4.2. Rheumatoid Factor (RF)
7.4.3. C-Reactive Protein (CRP)
7.4.4. Anti-Thyroglobulin Antibody (ATA)
7.4.5. Others
CHAPTER 8. AUTOIMMUNE DISEASE TESTING MARKET, BY END-USER
8.1. Market Snapshot
8.2. Global Autoimmune Disease Testing Market by End-user, Performance - Potential Analysis
8.3. Global Autoimmune Disease Testing Market Estimates & Forecasts by End-user 2020-2030 (USD Billion)
8.4. Autoimmune Disease Testing Market, Sub Segment Analysis
8.4.1. Hospital & Clinics
8.4.2. Diagnostic Centers
8.4.3. Others
CHAPTER 9. GLOBAL AUTOIMMUNE DISEASE TESTING MARKET, REGIONAL ANALYSIS
9.1. Top Leading Countries
9.2. Top Emerging Countries
9.3. Autoimmune Disease Testing Market, Regional Market Snapshot
9.4. North America Autoimmune Disease Testing Market
9.4.1. U.S. Autoimmune Disease Testing Market
9.4.1.1. Product Type breakdown estimates & forecasts, 2020-2030
9.4.1.2. Disease Type breakdown estimates & forecasts, 2020-2030
9.4.1.3. Test Type breakdown estimates & forecasts, 2020-2030
9.4.1.4. End-user breakdown estimates & forecasts, 2020-2030
9.4.2. Canada Autoimmune Disease Testing Market
9.5. Europe Autoimmune Disease Testing Market Snapshot
9.5.1. U.K. Autoimmune Disease Testing Market
9.5.2. Germany Autoimmune Disease Testing Market
9.5.3. France Autoimmune Disease Testing Market
9.5.4. Spain Autoimmune Disease Testing Market
9.5.5. Italy Autoimmune Disease Testing Market
9.5.6. Rest of Europe Autoimmune Disease Testing Market
9.6. Asia-Pacific Autoimmune Disease Testing Market Snapshot
9.6.1. China Autoimmune Disease Testing Market
9.6.2. India Autoimmune Disease Testing Market
9.6.3. Japan Autoimmune Disease Testing Market
9.6.4. Australia Autoimmune Disease Testing Market
9.6.5. South Korea Autoimmune Disease Testing Market
9.6.6. Rest of Asia Pacific Autoimmune Disease Testing Market
9.7. Latin America Autoimmune Disease Testing Market Snapshot
9.7.1. Brazil Autoimmune Disease Testing Market
9.7.2. Mexico Autoimmune Disease Testing Market
9.8. Middle East & Africa Autoimmune Disease Testing Market
9.8.1. Saudi Arabia Autoimmune Disease Testing Market
9.8.2. South Africa Autoimmune Disease Testing Market
9.8.3. Rest of Middle East & Africa Autoimmune Disease Testing Market
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Key Company SWOT Analysis
10.1.1. Company
10.1.2. Company
10.1.3. Company
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. F. Hoffmann-La Roche Ltd
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Recent Developments
10.3.2. Siemens Healthcare GmbH
10.3.3. Thermo Fisher Scientific Inc.
10.3.4. Quest Diagnostics Incorporated
10.3.5. Abbott
10.3.6. Werfen
10.3.7. Trinity Biotech PLC
10.3.8. Bio-Rad Laboratories, Inc.
10.3.9. ORGENTEC Diagnostika GmbH
10.3.10. Cambridge Life Sciences Limited
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Autoimmune Disease Testing Market, by Region, 2020-2030 (USD Billion)
1.2.2. Autoimmune Disease Testing Market, by Product Type, 2020-2030 (USD Billion)
1.2.3. Autoimmune Disease Testing Market, by Disease Type, 2020-2030 (USD Billion)
1.2.4. Autoimmune Disease Testing Market, by Test Type, 2020-2030 (USD Billion)
1.2.5. Autoimmune Disease Testing Market, by End-user, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL AUTOIMMUNE DISEASE TESTING MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL AUTOIMMUNE DISEASE TESTING MARKET DYNAMICS
3.1. Autoimmune Disease Testing Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing automation in a laboratory
3.1.1.2. Rising prevalence of autoimmune diseases
3.1.2. Market Challenges
3.1.2.1. Lack of penetration of these products in developing regions
3.1.2.2. Lack of awareness of these diseases amongst the general population
3.1.3. Market Opportunities
3.1.3.1. Rising adoption of biosensors for autoimmune disease testing
3.1.3.2. Growing expenditure on R&D activities
CHAPTER 4. GLOBAL AUTOIMMUNE DISEASE TESTING MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL AUTOIMMUNE DISEASE TESTING MARKET, BY PRODUCT TYPE
5.1. Market Snapshot
5.2. Global Autoimmune Disease Testing Market by Product Type, Performance - Potential Analysis
5.3. Global Autoimmune Disease Testing Market Estimates & Forecasts by Product Type 2020-2030 (USD Billion)
5.4. Autoimmune Disease Testing Market, Sub Segment Analysis
5.4.1. Instruments
5.4.2. Reagents & Consumables
CHAPTER 6. GLOBAL AUTOIMMUNE DISEASE TESTING MARKET, BY DISEASE TYPE
6.1. Market Snapshot
6.2. Global Autoimmune Disease Testing Market by Disease Type, Performance - Potential Analysis
6.3. Global Autoimmune Disease Testing Market Estimates & Forecasts by Disease Type 2020-2030 (USD Billion)
6.4. Autoimmune Disease Testing Market, Sub Segment Analysis
6.4.1. Rheumatoid Arthritis (RA)
6.4.2. Systemic Lupus Erythematosus (SLE)
6.4.3. Scleroderma
6.4.4. Vasculitis
6.4.5. Inflammatory Bowel Disease (IBD)
6.4.6. Others
CHAPTER 7. GLOBAL AUTOIMMUNE DISEASE TESTING MARKET, BY TEST TYPE
7.1. Market Snapshot
7.2. Global Autoimmune Disease Testing Market by Test Type, Performance - Potential Analysis
7.3. Global Autoimmune Disease Testing Market Estimates & Forecasts by Test Type 2020-2030 (USD Billion)
7.4. Autoimmune Disease Testing Market, Sub Segment Analysis
7.4.1. Antinuclear Autoantibody (ANA)
7.4.2. Rheumatoid Factor (RF)
7.4.3. C-Reactive Protein (CRP)
7.4.4. Anti-Thyroglobulin Antibody (ATA)
7.4.5. Others
CHAPTER 8. AUTOIMMUNE DISEASE TESTING MARKET, BY END-USER
8.1. Market Snapshot
8.2. Global Autoimmune Disease Testing Market by End-user, Performance - Potential Analysis
8.3. Global Autoimmune Disease Testing Market Estimates & Forecasts by End-user 2020-2030 (USD Billion)
8.4. Autoimmune Disease Testing Market, Sub Segment Analysis
8.4.1. Hospital & Clinics
8.4.2. Diagnostic Centers
8.4.3. Others
CHAPTER 9. GLOBAL AUTOIMMUNE DISEASE TESTING MARKET, REGIONAL ANALYSIS
9.1. Top Leading Countries
9.2. Top Emerging Countries
9.3. Autoimmune Disease Testing Market, Regional Market Snapshot
9.4. North America Autoimmune Disease Testing Market
9.4.1. U.S. Autoimmune Disease Testing Market
9.4.1.1. Product Type breakdown estimates & forecasts, 2020-2030
9.4.1.2. Disease Type breakdown estimates & forecasts, 2020-2030
9.4.1.3. Test Type breakdown estimates & forecasts, 2020-2030
9.4.1.4. End-user breakdown estimates & forecasts, 2020-2030
9.4.2. Canada Autoimmune Disease Testing Market
9.5. Europe Autoimmune Disease Testing Market Snapshot
9.5.1. U.K. Autoimmune Disease Testing Market
9.5.2. Germany Autoimmune Disease Testing Market
9.5.3. France Autoimmune Disease Testing Market
9.5.4. Spain Autoimmune Disease Testing Market
9.5.5. Italy Autoimmune Disease Testing Market
9.5.6. Rest of Europe Autoimmune Disease Testing Market
9.6. Asia-Pacific Autoimmune Disease Testing Market Snapshot
9.6.1. China Autoimmune Disease Testing Market
9.6.2. India Autoimmune Disease Testing Market
9.6.3. Japan Autoimmune Disease Testing Market
9.6.4. Australia Autoimmune Disease Testing Market
9.6.5. South Korea Autoimmune Disease Testing Market
9.6.6. Rest of Asia Pacific Autoimmune Disease Testing Market
9.7. Latin America Autoimmune Disease Testing Market Snapshot
9.7.1. Brazil Autoimmune Disease Testing Market
9.7.2. Mexico Autoimmune Disease Testing Market
9.8. Middle East & Africa Autoimmune Disease Testing Market
9.8.1. Saudi Arabia Autoimmune Disease Testing Market
9.8.2. South Africa Autoimmune Disease Testing Market
9.8.3. Rest of Middle East & Africa Autoimmune Disease Testing Market
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Key Company SWOT Analysis
10.1.1. Company
10.1.2. Company
10.1.3. Company
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. F. Hoffmann-La Roche Ltd
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Recent Developments
10.3.2. Siemens Healthcare GmbH
10.3.3. Thermo Fisher Scientific Inc.
10.3.4. Quest Diagnostics Incorporated
10.3.5. Abbott
10.3.6. Werfen
10.3.7. Trinity Biotech PLC
10.3.8. Bio-Rad Laboratories, Inc.
10.3.9. ORGENTEC Diagnostika GmbH
10.3.10. Cambridge Life Sciences Limited
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Autoimmune Disease Testing Market, report scope
TABLE 2. Global Autoimmune Disease Testing Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Autoimmune Disease Testing Market estimates & forecasts by Product Type 2020-2030 (USD Billion)
TABLE 4. Global Autoimmune Disease Testing Market estimates & forecasts by Disease Type 2020-2030 (USD Billion)
TABLE 5. Global Autoimmune Disease Testing Market estimates & forecasts by Test Type 2020-2030 (USD Billion)
TABLE 6. Global Autoimmune Disease Testing Market estimates & forecasts by End-user 2020-2030 (USD Billion)
TABLE 7. Global Autoimmune Disease Testing Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Autoimmune Disease Testing Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Autoimmune Disease Testing Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Autoimmune Disease Testing Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Autoimmune Disease Testing Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Autoimmune Disease Testing Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Autoimmune Disease Testing Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Autoimmune Disease Testing Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Autoimmune Disease Testing Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. Global Autoimmune Disease Testing Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. U.S. Autoimmune Disease Testing Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 18. U.S. Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. U.S. Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 20. Canada Autoimmune Disease Testing Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 21. Canada Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. Canada Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 23. UK Autoimmune Disease Testing Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 24. UK Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. UK Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 26. Germany Autoimmune Disease Testing Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 27. Germany Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. Germany Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 29. France Autoimmune Disease Testing Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 30. France Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. France Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 32. Italy Autoimmune Disease Testing Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 33. Italy Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Italy Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 35. Spain Autoimmune Disease Testing Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 36. Spain Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. Spain Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 38. RoE Autoimmune Disease Testing Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 39. RoE Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. RoE Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 41. China Autoimmune Disease Testing Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 42. China Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. China Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 44. India Autoimmune Disease Testing Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 45. India Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. India Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 47. Japan Autoimmune Disease Testing Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 48. Japan Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. Japan Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 50. South Korea Autoimmune Disease Testing Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 51. South Korea Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. South Korea Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 53. Australia Autoimmune Disease Testing Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 54. Australia Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. Australia Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 56. RoAPAC Autoimmune Disease Testing Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 57. RoAPAC Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. RoAPAC Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 59. Brazil Autoimmune Disease Testing Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 60. Brazil Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Brazil Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 62. Mexico Autoimmune Disease Testing Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 63. Mexico Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. Mexico Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 65. RoLA Autoimmune Disease Testing Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 66. RoLA Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. RoLA Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 68. Saudi Arabia Autoimmune Disease Testing Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 69. South Africa Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70. RoMEA Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 71. List of secondary sources, used in the study of global Autoimmune Disease Testing Market
TABLE 72. List of primary sources, used in the study of global Autoimmune Disease Testing Market
TABLE 73. Years considered for the study
TABLE 74. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
TABLE 1. Global Autoimmune Disease Testing Market, report scope
TABLE 2. Global Autoimmune Disease Testing Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Autoimmune Disease Testing Market estimates & forecasts by Product Type 2020-2030 (USD Billion)
TABLE 4. Global Autoimmune Disease Testing Market estimates & forecasts by Disease Type 2020-2030 (USD Billion)
TABLE 5. Global Autoimmune Disease Testing Market estimates & forecasts by Test Type 2020-2030 (USD Billion)
TABLE 6. Global Autoimmune Disease Testing Market estimates & forecasts by End-user 2020-2030 (USD Billion)
TABLE 7. Global Autoimmune Disease Testing Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Autoimmune Disease Testing Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Autoimmune Disease Testing Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Autoimmune Disease Testing Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Autoimmune Disease Testing Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Autoimmune Disease Testing Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Autoimmune Disease Testing Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Autoimmune Disease Testing Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Autoimmune Disease Testing Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. Global Autoimmune Disease Testing Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. U.S. Autoimmune Disease Testing Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 18. U.S. Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. U.S. Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 20. Canada Autoimmune Disease Testing Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 21. Canada Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. Canada Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 23. UK Autoimmune Disease Testing Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 24. UK Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. UK Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 26. Germany Autoimmune Disease Testing Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 27. Germany Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. Germany Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 29. France Autoimmune Disease Testing Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 30. France Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. France Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 32. Italy Autoimmune Disease Testing Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 33. Italy Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Italy Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 35. Spain Autoimmune Disease Testing Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 36. Spain Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. Spain Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 38. RoE Autoimmune Disease Testing Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 39. RoE Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. RoE Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 41. China Autoimmune Disease Testing Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 42. China Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. China Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 44. India Autoimmune Disease Testing Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 45. India Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. India Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 47. Japan Autoimmune Disease Testing Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 48. Japan Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. Japan Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 50. South Korea Autoimmune Disease Testing Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 51. South Korea Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. South Korea Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 53. Australia Autoimmune Disease Testing Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 54. Australia Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. Australia Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 56. RoAPAC Autoimmune Disease Testing Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 57. RoAPAC Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. RoAPAC Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 59. Brazil Autoimmune Disease Testing Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 60. Brazil Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Brazil Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 62. Mexico Autoimmune Disease Testing Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 63. Mexico Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. Mexico Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 65. RoLA Autoimmune Disease Testing Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 66. RoLA Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. RoLA Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 68. Saudi Arabia Autoimmune Disease Testing Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 69. South Africa Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70. RoMEA Autoimmune Disease Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 71. List of secondary sources, used in the study of global Autoimmune Disease Testing Market
TABLE 72. List of primary sources, used in the study of global Autoimmune Disease Testing Market
TABLE 73. Years considered for the study
TABLE 74. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Autoimmune Disease Testing Market, research methodology
FIG 2. Global Autoimmune Disease Testing Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Autoimmune Disease Testing Market, key trends 2022
FIG 5. Global Autoimmune Disease Testing Market, growth prospects 2023-2030
FIG 6. Global Autoimmune Disease Testing Market, porters 5 force model
FIG 7. Global Autoimmune Disease Testing Market, pest analysis
FIG 8. Global Autoimmune Disease Testing Market, value chain analysis
FIG 9. Global Autoimmune Disease Testing Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Autoimmune Disease Testing Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Autoimmune Disease Testing Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Autoimmune Disease Testing Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Autoimmune Disease Testing Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Autoimmune Disease Testing Market, regional snapshot 2020 & 2030
FIG 15. North America Autoimmune Disease Testing Market 2020 & 2030 (USD Billion)
FIG 16. Europe Autoimmune Disease Testing Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Autoimmune Disease Testing Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Autoimmune Disease Testing Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Autoimmune Disease Testing Market 2020 & 2030 (USD Billion)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
FIG 1. Global Autoimmune Disease Testing Market, research methodology
FIG 2. Global Autoimmune Disease Testing Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Autoimmune Disease Testing Market, key trends 2022
FIG 5. Global Autoimmune Disease Testing Market, growth prospects 2023-2030
FIG 6. Global Autoimmune Disease Testing Market, porters 5 force model
FIG 7. Global Autoimmune Disease Testing Market, pest analysis
FIG 8. Global Autoimmune Disease Testing Market, value chain analysis
FIG 9. Global Autoimmune Disease Testing Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Autoimmune Disease Testing Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Autoimmune Disease Testing Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Autoimmune Disease Testing Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Autoimmune Disease Testing Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Autoimmune Disease Testing Market, regional snapshot 2020 & 2030
FIG 15. North America Autoimmune Disease Testing Market 2020 & 2030 (USD Billion)
FIG 16. Europe Autoimmune Disease Testing Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Autoimmune Disease Testing Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Autoimmune Disease Testing Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Autoimmune Disease Testing Market 2020 & 2030 (USD Billion)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
